Literature DB >> 11014411

Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock.

E Bellissant1, D Annane.   

Abstract

BACKGROUND: Septic shock is characterized by decreased responsiveness to catecholamines. Because endogenous steroids are known to play a role in the modulation of vasomotor tone, the purpose of our study was to investigate the phenylephrine-mean arterial pressure dose-response relationship in patients with septic shock and the effect of a physiological dose of hydrocortisone on it.
METHODS: Twelve patients meeting usual criteria for septic shock and 12 age-matched control subjects were investigated before and 1 hour after receiving 50 mg intravenous hydrocortisone. Sixteen incremental doses of phenylephrine (microg/kg/min) were infused, and the effects on mean arterial pressure (mm Hg) were recorded. A sigmoid model, E = E0 + [Emax x Dgamma/(ED50gamma + Dgamma)], was fitted to individual data. In this model, E is the predicted effect and D is the dose of phenylephrine infused. E0 represents the basal value of effect (ie, the value of mean arterial pressure without drug), Emax is the maximum theoretical effect, ED50 is the dose of phenylephrine for which an effect of 50% of Emax is observed, and gamma is the Hill coefficient which accounts for the sigmoidicity of the curve.
RESULTS: As compared with in control subjects, in patients, E0 was decreased before (58 +/- 8 versus 73 +/- 7 mm Hg) and after (64 +/- 12 versus 82 +/- 10 mm Hg) administration of hydrocortisone (P = .0001 for group), Emax was reduced before (39 +/- 17 versus 84 +/- 18 mm Hg) and after (77 +/- 26 versus 106 +/- 21 mm Hg) administration of hydrocortisone (P = .0001 for group), ED50 was not modified, and gamma was increased before (3.5 +/- 1.8 versus 1.3 +/- 0.3) and after (1.9 +/- 1.1 versus 1.3 +/- 0.3) administration of hydrocortisone (P = .0010 for group). Hydrocortisone similarly increased E0 in both groups (P = .0003 for sequence, P = .2883 for interaction), increased more Emax in patients than in control subjects (P < .0001 for sequence; P = .0280 for interaction), did not change ED50, and decreased y in patients but not in control subjects (P = .0025 for sequence, P = .0025 for interaction).
CONCLUSIONS: In patients with septic shock, the Emax of phenylephrine is decreased, whereas its ED50 is not modified, both before and after administration of hydrocortisone. A physiological dose of hydrocortisone tends to normalize the relationship.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014411     DOI: 10.1067/mcp.2000.109354

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Neal H. Steigbigel
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.

Authors:  Bruno Laviolle; Erwan Donal; Pascale Le Maguet; Fabrice Lainé; Eric Bellissant
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

3.  Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy.

Authors:  Jerome Morel; Christophe Venet; Yannis Donati; David Charier; Jerome Liotier; Delphine Frere-Meunier; Stephane Guyomarc'h; Eric Diconne; Jean Claude Bertrand; Bertrand Souweine; Laurent Papazian; Fabrice Zeni
Journal:  Intensive Care Med       Date:  2006-06-20       Impact factor: 17.440

4.  [Hydrocortisone in sepsis. A physiological concept without effect?].

Authors:  M Ragaller; S Nitschmann
Journal:  Internist (Berl)       Date:  2008-08       Impact factor: 0.743

5.  Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.

Authors:  Yaseen M Arabi; Abdulrahman Aljumah; Ousama Dabbagh; Hani M Tamim; Asgar H Rishu; Abdulmajeed Al-Abdulkareem; Bandar Al Knawy; Ali H Hajeer; Waleed Tamimi; Antoine Cherfan
Journal:  CMAJ       Date:  2010-11-08       Impact factor: 8.262

Review 6.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Low-dose and high-dose synacthen tests and the hemodynamic response to hydrocortisone in acute traumatic brain injury.

Authors:  R S Wijesurendra; F Bernard; J Outtrim; B Maiya; S Joshi; P J Hutchinson; D J Halsall; D K Menon
Journal:  Neurocrit Care       Date:  2009-04-29       Impact factor: 3.210

8.  Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity.

Authors:  R d'Emmanuele di Villa Bianca; L Lippolis; G Autore; A Popolo; S Marzocco; L Sorrentino; A Pinto; R Sorrentino
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

9.  Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort study.

Authors:  Yun-Shing Peng; Cheng-Shyong Wu; Yung-Chang Chen; Jau-Min Lien; Ya-Chung Tian; Ji-Tseng Fang; Chun Yang; Yun-Yi Chu; Chien-Fu Hung; Chih-Wei Yang; Pang-Chi Chen; Ming-Hung Tsai
Journal:  Crit Care       Date:  2009-07-24       Impact factor: 9.097

10.  CORTICUS: the end of unconditional love for steroid use?

Authors:  Phillip E Mason; Ali Al-Khafaji; Eric B Milbrandt; Brian P Suffoletto; David T Huang
Journal:  Crit Care       Date:  2009-08-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.